NO20051983D0 - 3-fenyl-substituert pyridoindolon, fremstilling derav og terapeutisk anvendelse derav. - Google Patents

3-fenyl-substituert pyridoindolon, fremstilling derav og terapeutisk anvendelse derav.

Info

Publication number
NO20051983D0
NO20051983D0 NO20051983A NO20051983A NO20051983D0 NO 20051983 D0 NO20051983 D0 NO 20051983D0 NO 20051983 A NO20051983 A NO 20051983A NO 20051983 A NO20051983 A NO 20051983A NO 20051983 D0 NO20051983 D0 NO 20051983D0
Authority
NO
Norway
Prior art keywords
phenyl
preparation
therapeutic use
pyridoindolone
substituted
Prior art date
Application number
NO20051983A
Other languages
English (en)
Other versions
NO20051983L (no
NO331297B1 (no
Inventor
Pierre Casellas
Yvette Muneaux
Bernard Bourrie
Jean-Marie Derocq
Samir Jegham
Paola Ciapetti
Camille-Georges Wermuth
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20051983D0 publication Critical patent/NO20051983D0/no
Publication of NO20051983L publication Critical patent/NO20051983L/no
Publication of NO331297B1 publication Critical patent/NO331297B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
NO20051983A 2002-10-23 2005-04-22 3-fenyl-substituert pyridoindolon, fremgangsmate for fremstilling derav, farmasoytisk preparat samt anvendelse NO331297B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0213264A FR2846329B1 (fr) 2002-10-23 2002-10-23 Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
PCT/FR2003/003110 WO2004041817A1 (fr) 2002-10-23 2003-10-21 Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique.

Publications (3)

Publication Number Publication Date
NO20051983D0 true NO20051983D0 (no) 2005-04-22
NO20051983L NO20051983L (no) 2005-07-22
NO331297B1 NO331297B1 (no) 2011-11-21

Family

ID=32088223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051983A NO331297B1 (no) 2002-10-23 2005-04-22 3-fenyl-substituert pyridoindolon, fremgangsmate for fremstilling derav, farmasoytisk preparat samt anvendelse

Country Status (33)

Country Link
US (2) US7390818B2 (no)
EP (1) EP1556382B1 (no)
JP (1) JP4488899B2 (no)
KR (1) KR101051859B1 (no)
CN (1) CN100345850C (no)
AR (1) AR041689A1 (no)
AT (1) ATE396994T1 (no)
AU (1) AU2003296769B2 (no)
BR (1) BR0314883A (no)
CA (1) CA2502769C (no)
CY (1) CY1109785T1 (no)
DE (1) DE60321372D1 (no)
DK (1) DK1556382T3 (no)
EA (1) EA010833B1 (no)
ES (1) ES2304546T3 (no)
FR (1) FR2846329B1 (no)
HK (1) HK1074446A1 (no)
HR (1) HRP20050362B1 (no)
IL (1) IL168133A (no)
IS (1) IS2641B (no)
MA (1) MA27455A1 (no)
ME (1) ME00102B (no)
MX (1) MXPA05004349A (no)
NO (1) NO331297B1 (no)
NZ (1) NZ539866A (no)
PL (1) PL214867B1 (no)
PT (1) PT1556382E (no)
RS (1) RS51605B (no)
SI (1) SI1556382T1 (no)
TW (1) TWI325864B (no)
UA (1) UA79317C2 (no)
WO (1) WO2004041817A1 (no)
ZA (1) ZA200503231B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823975B1 (fr) 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
US7456193B2 (en) 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
US20100297252A1 (en) * 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
FR2869316B1 (fr) * 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2876377B1 (fr) * 2004-10-11 2007-03-16 Univ Claude Bernard Lyon Nouveaux derives de 9h-pyrido[2,3-b]indole, leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique
FR2959133A1 (fr) 2010-04-22 2011-10-28 Sanofi Aventis Formulation pharmaceutique anticancereuse
FR2945950A1 (fr) 2009-05-27 2010-12-03 Elan Pharma Int Ltd Compositions de nanoparticules anticancereuses et procedes pour les preparer
HUE032426T2 (en) 2009-05-27 2017-09-28 Alkermes Pharma Ireland Ltd Inhibition of flake aggregation in nanoparticulate meloxicam formulations
CN107459481A (zh) * 2017-07-25 2017-12-12 广州大学 一种3‑（4‑甲氧基苯基）‑6‑甲氧基‑4‑氯‑5,7‑二溴喹啉的合成方法
US20230056559A1 (en) * 2019-02-01 2023-02-23 Medshine Discovery Inc. Pyrimidinyl group-containing tricyclic compound serving as c-met inhibitor
CN113329276B (zh) * 2020-02-28 2022-10-28 华为技术有限公司 数据传输方法、装置、网关、芯片及存储介质
CN116171156A (zh) * 2020-07-31 2023-05-26 南京明德新药研发有限公司 含嘧啶基团的三并环类化合物的盐型、晶型及其制备方法
CA3221565A1 (en) * 2021-05-26 2022-12-01 Refined Technologies, Inc. Compositions and methods for removal of n-methyl-2-pyrrolidone (nmp) degradation products and other foulants from nmp purification systems

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268772A (en) 1968-03-15 1972-03-29 Glaxo Lab Ltd NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US4263304A (en) * 1978-06-05 1981-04-21 Sumitomo Chemical Company, Limited 7 H-indolo[2,3-c]isoquinolines
SU833971A1 (ru) 1979-07-10 1981-05-30 Ленинградский Химико-Фармацевтическийинститут Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ
FR2595701B1 (fr) * 1986-03-17 1988-07-01 Sanofi Sa Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant
ATE386131T1 (de) 1994-04-13 2008-03-15 Univ Rockefeller Aav-vermittelte überbringung von dna in zellen des nervensystems
DE19502753A1 (de) * 1995-01-23 1996-07-25 Schering Ag Neue 9H-Pyrido[3,4-b]indol-Derivate
FR2765582B1 (fr) 1997-07-03 1999-08-06 Synthelabo Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
FR2765581B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
EP1068205A1 (en) 1998-04-02 2001-01-17 Neurogen Corporation Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino 2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino 4,5-b]indole derivatives: crf1 specific ligands
IT1313592B1 (it) * 1999-08-03 2002-09-09 Novuspharma Spa Derivati di 1h-pirido 3,4-b indol-1-one.
US20020156016A1 (en) 2001-03-30 2002-10-24 Gerald Minuk Control of cell growth by altering cell membrane potentials
FR2823975B1 (fr) * 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846330B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
US7456193B2 (en) * 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2869316B1 (fr) 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
FR2846329A1 (fr) 2004-04-30
US20050288318A1 (en) 2005-12-29
EA200500521A1 (ru) 2005-12-29
IS7815A (is) 2005-04-20
US8012991B2 (en) 2011-09-06
WO2004041817A1 (fr) 2004-05-21
SI1556382T1 (sl) 2008-10-31
BR0314883A (pt) 2005-08-02
EP1556382B1 (fr) 2008-05-28
ME00102B (me) 2010-10-10
MEP22208A (en) 2010-06-10
HRP20050362B1 (hr) 2014-01-31
EA010833B1 (ru) 2008-12-30
PT1556382E (pt) 2008-07-09
UA79317C2 (en) 2007-06-11
AU2003296769A1 (en) 2004-06-07
NO20051983L (no) 2005-07-22
TW200413368A (en) 2004-08-01
EP1556382A1 (fr) 2005-07-27
ZA200503231B (en) 2006-06-28
AR041689A1 (es) 2005-05-26
CA2502769A1 (en) 2004-05-21
NO331297B1 (no) 2011-11-21
US7390818B2 (en) 2008-06-24
ES2304546T3 (es) 2008-10-16
DK1556382T3 (da) 2008-10-06
ATE396994T1 (de) 2008-06-15
PL376790A1 (pl) 2006-01-09
JP4488899B2 (ja) 2010-06-23
HRP20050362A2 (en) 2005-12-31
CY1109785T1 (el) 2014-09-10
RS51605B (en) 2011-08-31
JP2006511498A (ja) 2006-04-06
CN100345850C (zh) 2007-10-31
CN1729190A (zh) 2006-02-01
RS20050362A (en) 2007-11-15
DE60321372D1 (de) 2008-07-10
US20080214538A1 (en) 2008-09-04
KR101051859B1 (ko) 2011-07-25
CA2502769C (en) 2011-03-15
IL168133A (en) 2010-05-31
PL214867B1 (pl) 2013-09-30
MXPA05004349A (es) 2005-08-26
FR2846329B1 (fr) 2004-12-03
MA27455A1 (fr) 2005-07-01
HK1074446A1 (en) 2005-11-11
KR20050086421A (ko) 2005-08-30
IS2641B (is) 2010-08-15
NZ539866A (en) 2008-01-31
AU2003296769B2 (en) 2010-02-04
TWI325864B (en) 2010-06-11

Similar Documents

Publication Publication Date Title
NO20051983D0 (no) 3-fenyl-substituert pyridoindolon, fremstilling derav og terapeutisk anvendelse derav.
NO20052855D0 (no) Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
NO20035298D0 (no) CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler
NO20053817D0 (no) Preparater og fremgangsmater for antiviral kombinasjonsterapi.
DK1641822T3 (da) Heterologe il-17-a/f-polypeptider og terapeutiske anvendelser deraf.
HK1061679A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use.
DK1455785T3 (da) Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse
HK1076110A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
NO20053974D0 (no) Tienopyrimidinforbindelser og anvendelse derav.
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
DK1511734T3 (da) Forbindelser, præparater og fremgangsmåder
DK1590321T3 (da) Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
DK1753725T3 (da) Tetra-hydro-iso-quinolinsulfonamidderivater, fremstilling og terapeutisk anvendelse heraf.
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
DK1773829T3 (da) Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf
DK1525193T3 (da) Acylaminothiazolderivater, deres fremstilling og deres terapeutiske anvendelse
IS2487B (is) Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á
DK1791872T3 (da) Biotinylerede hexadecasaccharider, farmaceutiske præparater og anvendelse heraf
IS7694A (is) Sterasamrunaefnasambönd, framleiðsla og notkun þeirra
ZA200210316B (en) Composition and its therapeutic use.
NO20033120L (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmåter for fremstilling derav og terapeutisk anvendelse derav
NO20053805D0 (no) Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav
NO20044090L (no) Substituert 3-fenyl-5-alkoksy-1,3,4-oksadiazol-24neJr, fremstilling derav og anvendelse i medikamenter
IL161859A0 (en) 3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees